President Donald Trump unveiled a deal this month with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. kAmz?@H? 2D v{!\` C646AE@C 28@?:DED[ E96 5CF8D D@2C65 :? A@AF=2C:EJ :? C646?E J62CD 3FE A2E:6?E 2446DD H2D 2 4@?D:DE6?E AC@3=6> 3642FD6 @7 E96:C 4@DE — 23@FE Sd__ 2 >@?E9 7@C 9:896C 5@D6D — 2?5 :?DFC2?46 4@G6C286 H2D DA@EEJ] |@C6 E92? `__ >:==:@? p>6C:42? 25F=ED 2C6 @36D6[ 244@C5:?8 E@ 7656C2= 6DE:>2E6D]k^Am kAmr@G6C286 @7 E96 5CF8D 7@C @36D:EJ H:== 6IA2?5 E@ |65:42C6 A2E:6?ED DE2CE:?8 ?6IE J62C[ 244@C5:?8 E@ E96 25>:?:DEC2E:@?[ H9:49 D2:5 D@>6 =@H6C AC:46D 2=D@ H:== 36 A92D65 :? 7@C A2E:6?ED H:E9@FE 4@G6C286]k^Am kAmQWxEX H:== D2G6 =:G6D[ :>AC@G6 E96 962=E9 @7 >:==:@?D 2?5 >:==:@?D @7 p>6C:42?D[Q %CF>
Deal announced with makers of GLP-1 obesity medications
St. Louis Post-Dispatch2 hrs ago
911


AlterNet
New York Post
NBC News
America News
Local News in Florida
Raw Story
Rotten Tomatoes
The Hill Politics